Detalhe da pesquisa
1.
High-Throughput Antigen Microarray Identifies Longitudinal Prognostic Autoantibody for Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer.
Mol Cell Proteomics
; 23(5): 100749, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38513890
2.
Proteomics Identifies Circulating TIMP-1 as a Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.
Mol Cell Proteomics
; 22(9): 100625, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37500057
3.
Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray.
Cancer
; 130(8): 1257-1269, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133926
4.
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
Cancer Immunol Immunother
; 73(3): 47, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349411
5.
Human Autoantigen Atlas: Searching for the Hallmarks of Autoantigens.
J Proteome Res
; 22(6): 1800-1815, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183442
6.
Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays.
Cancer Immunol Immunother
; 72(1): 235-247, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35831618
7.
High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
Cancer Sci
; 113(2): 770-783, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34843149
8.
Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy.
Cancer Immunol Immunother
; 71(7): 1681-1691, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34817638
9.
Cytokines screening identifies MIG (CXCL9) for postoperative recurrence prediction in operated non-small cell lung cancer patients.
Cytokine
; 149: 155759, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775109
10.
Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta-analysis.
Scand J Immunol
; 91(2): e12829, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31536647
11.
Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy.
J Transl Med
; 17(1): 339, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31597567
12.
Radiation therapy in the era of immune treatment for hepatocellular carcinoma.
Front Immunol
; 14: 1100079, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36742293
13.
An immunosuppressive subtype of senescent tumor cells predicted worse immunotherapy response in lung adenocarcinoma.
iScience
; 26(10): 107894, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766998
14.
Gut Streptococcus is a microbial marker for the occurrence and liver metastasis of pancreatic cancer.
Front Microbiol
; 14: 1184869, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37389332
15.
Case report: A rare case of neutropenia caused by pembrolizumab in squamous lung cancer and literature review.
Front Oncol
; 12: 973421, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505877
16.
Development and validation of a UPLC-MS/MS method to quantitate anti-PD1 monoclonal antibody (Toripalimab), and comparison with electrochemiluminescence immunoassay.
J Pharm Biomed Anal
; 209: 114515, 2022 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34894461
17.
SLF1 polymorphism predicts response to oxaliplatin-based adjuvant chemotherapy in patients with colon cancer.
Am J Cancer Res
; 11(4): 1522-1539, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33948371
18.
Autoantibody profiling identifies predictive biomarkers of response to anti-PD1 therapy in cancer patients.
Theranostics
; 10(14): 6399-6410, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483460
19.
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK.
Curr Cancer Drug Targets
; 19(8): 655-665, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30381078
20.
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I-III Lung Adenocarcinoma.
Front Oncol
; 9: 556, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31448219